Murine obscurin and Obsl1 have functionally redundant roles in sarcolemmal integrity, sarcoplasmic reticulum organization, and muscle metabolism by Blondelle, J. et al.
ARTICLE
Murine obscurin and Obsl1 have functionally
redundant roles in sarcolemmal integrity,
sarcoplasmic reticulum organization, and muscle
metabolism
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Biological roles of obscurin and its close homolog Obsl1 (obscurin-like 1) have been enig-
matic. While obscurin is highly expressed in striated muscles, Obsl1 is found ubiquitously.
Accordingly, obscurin mutations have been linked to myopathies, whereas mutations in Obsl1
result in 3M-growth syndrome. To further study unique and redundant functions of these
closely related proteins, we generated and characterized Obsl1 knockouts. Global Obsl1
knockouts are embryonically lethal. In contrast, skeletal muscle-specific Obsl1 knockouts
show a benign phenotype similar to obscurin knockouts. Only deletion of both proteins and
removal of their functional redundancy revealed their roles for sarcolemmal stability and
sarcoplasmic reticulum organization. To gain unbiased insights into changes to the muscle
proteome, we analyzed tibialis anterior and soleus muscles by mass spectrometry, unco-
vering additional changes to the muscle metabolism. Our analyses suggest that all obscurin
protein family members play functions for muscle membrane systems.
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G iant muscle proteins have been known for a long time toplay important functions for skeletal and cardiac devel-opment and function, as well as for pathology of myo-
pathies. Among the best characterized of these cellular giants are
titin (also called connectin; approx. 3.5 MDa), and obscurin
(approx. 800 kDa). Similar to titin, proteins of the obscurin
protein family combine structural with signaling functions.
Obscurin, the biggest mammalian member of this protein family,
consists of serially arranged immunoglobulin-like and
fibronectin-type III domains that are interspersed with signaling
domains1,2. Unlike titin, obscurin contains in addition to its
protein kinase domains also a calcium/calmodulin-binding IQ
motif, as well as a RhoGEF domain triplet (SH3-DH-PH
domains). Extensive splicing of the obscurin gene results in at
least three main transcripts, the giant obscurin-A and obscurin-B
splice isoforms, and the obscurin kinase only (also known as
KIAA1639 or Obsc-kin), which originates from a separate pro-
moter3. Recent reports indicate the presence of smaller obscurin
splice variants4, their expression in non-muscle tissues, and
important functions for tumorigenicity and metastasis5–7. Other
members of the obscurin protein family are the ubiquitously
expressed obscurin-like 1 (Obsl1)8 as well as the striated muscle/
atrial preferentially expressed protein kinase (Speg, also known as
Apeg)9. Evolutionary, all members of the obscurin family are
thought to have originated from one ancestral gene2,8. This idea is
supported by the fact that invertebrates like Caenorhabditis ele-
gans have one obscurin family ortholog called unc-8910. In
addition, Obsl1 and Speg show sequence similarity to the
obscurin N and C terminus, respectively, and at least for Obsl1
also a certain degree of functional redundancy8,11.
Knockout models for obscurin and Speg have been helpful to
delineate biological functions of these genes/proteins. While the
knockout for obscurin resulted in a mild skeletal myopathy,
changes to the sarcoplasmic reticulum (SR) and membrane fra-
gility after exercise12–14, Speg knockouts displayed a prominent
dilated cardiomyopathy, disruption of the junctional SR mem-
brane, and centronucleolar myopathy15–17.
Lately, it emerged that mutations in the human Obsl1 result in
3M-growth syndrome in affected patients. On the molecular level,
many of the human Obsl1 mutations are thought to result in
nonsense-mediated decay of its messenger RNA (mRNA) and
ultimately loss of the protein. However, owing to the extensive
splicing displayed by Obsl18 (Supplementary Fig. 1a), detailed
investigations into which isoforms are affected/unaffected and their
respective expression levels in patient tissues remain to be done.
The sarcomeric proteins titin and myomesin-1 have been
identified as interaction partners for both obscurin and Obsl1.
Titin offers two binding sites to obscurin: the titin C-terminal Ig-
domain M10 interacts with obscurin Ig-domain 111, while titin
domains Z9–Z10 were identified to bind to obscurin Ig domains
Ig48-Ig49 (also called Ig58-Ig59, depending on the obscurin splice
isoform)2. Interaction of obscurin with the titin C terminus is the
predominant binding site in mature myofilaments, giving rise to
the prominent M-band colocalization of obscurin. The titin
binding site in Ig-domain 1 of obscurin is evolutionary conserved
for Obsl1 Ig-domain 1, albeit with a higher affinity compared to
obscurin18. Differences in the side chains in obscurin vs. Obsl1
that generate the titin interaction interface and account for the
differential binding affinity also contribute to the slightly different
intracellular sorting of obscurin vs. Obsl1. Mutations in titin Ig-
domain M10 that are known to cause limb-girdle muscular
dystrophy 2J in affected patients were shown to disrupt the
interaction with obscurin or Obsl111. Indeed, biochemical ana-
lyses of the various titin mutations found in titin Ig-domain M10
indicated that the severity of the muscular dystrophy correlates
with the degree of loss of interaction to obscurin or Obsl1.
The functional redundancy between Obsl1 and obscurin can
also be seen in their association with myomesin-111. Recent
advances in the co-crystallization of this interaction revealed that
binding of myomesin-1 to obscurin or Obsl1 Ig3 is necessary for
proper folding of their Ig domains in a hitherto unprecedented
trans-complementation mechanism19.
Another well-characterized binding site for a muscle-specific
isoform of ankyrin-1 (sAnk1.5) is located within the obscurin-A
isoform C terminus20,21. Complex formation between obscurin,
sAnk1.5, and tropomodulin-3 was demonstrated to be important
for SR architecture and function12,22,23, and stability of sAnk1.5
itself. Indeed, we demonstrated that loss of obscurin leads to
increased sAnk1.5 turnover in a cullin-3/KCTD6-dependent
manner24. Intriguingly, the functional property that obscurins
may regulate the stability and turnover of their interaction part-
ners may be conserved within this protein family, as well as
evolutionary: Obsl1 interacts with cullin-725,26, and dysfunction
of this E3-ligase complex by mutations in cullin-7 or Obsl1 have
been linked to the development of 3M-growth syndrome in
patients27,28. Moreover, the invertebrate obscurin homolog unc-
89 directly interacts with cullin-1, and regulates myosin filament
organization in a MEL-26/cullin-3- and MEI-1 (katanin)-
dependent way24,29.
In this study, we set out to further investigate biological functions
for obscurin proteins for skeletal muscles, with a special emphasis to
uncover functional redundancies between obscurin and Obsl1. As
Obsl1 is ubiquitously expressed and its mutations lead to a growth
disorder in affected patients, we also investigated the phenotype of
global Obsl1-knockout mice. Our studies uncovered that global
Obsl1 knockouts are embryonically lethal, while skeletal muscle-
specific Obsl1 knockouts show a mild phenotype similar to
obscurin knockouts. Only deletion of both proteins in skeletal
muscles uncovered their role for SR, cellular calcium storage and
handling, dystrophin–sarcoglycan (DSG) complex, and sarco-
lemmal integrity, as well as changes to the muscle metabolism.
Results
Global knockout mice for Obsl1 are embryonically lethal. We
generated the Obsl1 conditional knockout mouse to test the effect
that ablation of Obsl1 would have on the whole organism, and on
skeletal muscle organization and function. Due to its extensive
splicing8 and the presence of alternative start codons, we decided
to place coding exons 1 through 4 of the murine Obsl1 locus
within LoxP sites (Supplementary Fig. 1a). This strategy should
result in the total ablation of any Obsl1 isoform (Supplementary
Fig. 1b). By crossing gene-targeted mice, with protamine-Cre
recombinase mice30, we generated global Obsl1 knockouts. Sur-
prisingly, global ablation of Obsl1 in mice results in embryonic
lethality before embryonic day E8 (Table 1), while mice hetero-
zygous for Obsl1 developed normally. These results are in con-
trast to reports on human patients carrying various mutations in
Obsl1, which are thought to result in nonsense-mediated decay of
its mRNA in a majority of cases. Clinically, these patients present
with the development of 3M-growth syndrome28,31.
Obsl1 and/or obscurin are not required for sarcomerogenesis
and skeletal muscle development. To overcome the lethality, we
crossed conditional Obsl1 mice with mice expressing Cre
recombinase under control of the myogenin promoter32. These
mice do not develop gross morphological abnormalities or display
premature death. However, it was shown that obscurin and Obsl1
display functional redundancy for two of their common inter-
action partners, namely myomesin-1 (Myom1) and titin’s C-
terminal domain M1011. Loss of obscurin was shown to result in
a mild myopathy phenotype, without adversely affecting the
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animals at baseline12. To investigate if the lack of a more pro-
nounced skeletal muscle phenotype might be due to a rescue by
Obsl1, we generated skeletal muscle-specific double knockouts
(dKO; Fig. 1a). dKO mice were viable, fertile, and developed
normally. Deletion of obscurin led to slightly increased protein
levels in Obsl1 (normalized protein levels 2.5 ± 0.1 in obscurin vs.
1.0 ± 0.02 in CTL; p < 0.001, n= 4), while obscurin expression
was unchanged in Obsl1-knockout TA muscles (Fig. 1a, Supple-
mentary Fig. 1c). Microscopic analysis of myofilament structure
using sarcomeric α-actinin 2 indicated normal sarcomerogenesis
(Fig. 1b, c, Supplementary Fig. 1d, h). Loss of Obsl1 or obscurin
(Obsc) does not alter localization of the other obscurin protein
family member in tibialis anterior (TA) muscles (Fig. 1b, c).
However, we noticed that two knockout validated Obsl1 anti-
bodies recognizing different epitopes within the protein displayed
differential localizations of Obsl1 within the sarcomere. An
antibody that was raised against N-terminal Ig-domain 1 of the
protein11 displayed M-band and Z-disc localization (Fig. 1c),
while a commercially available antibody that recognizes Ig-
domain 14 of Obsl1 localized almost exclusively to Z-discs
(Supplementary Fig. 1d).
Loss of unc-89 in Caenorhabditis elegans and in Drosophila
results in the disruption of myosin lattice organization, partially due
to loss of the RhoGEF activity in the invertebrate obscurin
homolog33,34. While searching for novel interaction partners for
Obsl1 by yeast two-hybrid screening, we identified the C terminus
of myosin (MyH6), dystonin (Dst), and filamin-C (FlnC) as
putative binding partners (Supplementary Fig. 1a, lower panel).
Both dystonin and FlnC were previously identified in another high-
throughput affinity assay as putative Obsl1 interaction partners35.
Analysis of myosin binding to Obsl1 by co-immunoprecipitation
validated their association (Supplementary Fig. 1e). However,
looking at protein expression and localization for some of the newly
and previously reported putative interaction partners like myome-
sin-1, no overt changes in protein levels, organization, and
subcellular localization were observable in immunoblots or
immunofluorescence images of longitudinal TA sections (Supple-
mentary Fig. 1f, g). In addition, unlike in C. elegans or Drosophila,
loss of obscurin and/or Obsl1 did not result in markedly altered Z-
disc and M-band structures (Supplementary Fig. 1h).
We next wondered what impact the loss of Obsl1 and/or
obscurin would have on muscle mass and cross-sectional muscle
area. Normalized muscle masses for TA, soleus (Sol) and
gastrocnemius (Gas), was unchanged in 4-month-old animals.
We observed only a small increase in the mass of extensor
digitorum longus (EDL) muscle of Obsl1-knockout animals
(Fig. 2a). No significant changes were observed in the number of
centralized nuclei in TA muscle at 4 months of age (Fig. 2b, c),
confirming earlier observations for muscles from obscurin
knockouts12. Study of cross-sectional areas in sections of TA
muscle revealed increases in fiber sizes in Obsl1 and obscurin-
knockout mice, probably responsible for the slight increase in
muscle mass of the Obsl1 animals, while dKO mice displayed
Table 1 Genotype analysis of global Obsl1-knockout mice
Genotype Number and % of embryos/animals in genotyping analysis Expected Mendelian ratios
E7–E8.5 E10.5–E13.5 E17–E18 P21
Control (+/+) 7 (30%) 15 (44%) 4 (33%) 37 (36%) 25%
Heterozygous (+/−) 16 (70%) 19 (56%) 8 (67%) 66 (64%) 50%
Knockout (−/−) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 25%
Obsl1 obscurin-like 1
CTL
Obsl1
a
b
c
CTL
Obsc
Obsl1
dKO
CTL
Obsc
Obsl1
dKO
Obsc lQ-64 α-Actinin
ObsI1-Ig1 α-Actinin
200
800
*
200
Obscurin
Ponceau
(myosin band)
Obsc Obsl1 dKO
Fig. 1 Expression and localization of obscurin and Obsl1 (obscurin-like 1) in
tibialis anterior (TA) muscles. a Expression levels of obscurin and Obsl1 in
TA muscles from obscurin-knockout (Obsc), Obsl1 skeletal muscle-
knockout (Obsl1), and double-knockout (dKO) mice, compared to controls
(CTL). Asterisk denotes non-specific cross-reactivity of the secondary
antibody with myosin. Myosin band in Ponceau stain as a loading control.
b, c Sarcomeric localization of obscurin (b, IQ-64 epitope antibody) or Obsl1
(c, Ig1 epitope antibody) in Obsc, Obsl1, and dKO, as well as control (CTL)
TA muscles. Arrows indicate Z-disc localizations as indicated by α-actinin 2
counterstain, while arrowheads signify the sarcomeric M-band. Please note
that some background staining caused by non-specific cross-reactivity of
the antibodies is observed in knockout tissues. Scale bars= 10 µm
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decreases in fiber sizes, specifically of fibers with high cross-
sectional areas (Fig. 2d, e).
Loss of obscurin/Obsl1 impacts the DSG complex and its
associated proteins. Obscurin has been reported to be important
for sarcolemmal integrity, and loss of the protein results in
changes to the subsarcolemmal microtubule network, increased
membrane fragility, and reduced running performance of
mice13,14. We investigated if changes to sarcolemmal integrity
and the DSG complex and its associated proteins are exacerbated
in Obsl1 and/or dKO mice. Loss of both obscurin and Obsl1
reduced protein levels of some DSG components, while levels of
tubulin increased slightly (p= 0.06). In addition, overall levels of
dystrophin and β1D- integrin remained unchanged (Fig. 3a,
Supplementary Figs. 2a, 7a). However, analysis of sub-
sarcolemmal dystrophin localization in longitudinal sections of
TA muscles revealed a patchy and abnormal distribution of the
protein in obscurin knockouts, but more so in dKO mice, indi-
cating enhanced membrane fragility even at baseline (Fig. 3b,
Supplementary Fig. 2b). Indeed, when investigated for the pre-
sence of mouse immunoglobulins in immunofluorescence assays,
a significant portion of muscle fibers in dKO mice stained positive
(Fig. 3c, Supplementary Fig. 2c). Increased membrane fragility in
dKO muscles also leads to significantly enhanced expression of
dysferlin (Dysf) and FlnC, proteins involved in repair and com-
pensatory mechanisms (Fig. 3d, Supplementary Figs. 2d, 7a).
The DSG complex also regulates expression and function of
sarcolemma-based membrane channels and signaling. Specifi-
cally, α-syntrophin has been demonstrated to establish a link
between dystrophin/the DSG complex and sarcolemmal ion
channels, such as Trpc1 as well as caveolae components and
neuronal nitric oxidase (nNOS) signaling. When investigated, we
noticed reduced caveolin-1 and Trpc1 levels in TA muscles of
dKO mice, while nNOS remained unchanged (Fig. 3e, Supple-
mentary Figs. 2e, 7a). Levels of L-type calcium channel remained
also comparable with controls, indicating potential changes to
DSG-associated, but not T-tubule-based ion channels.
Proteome analysis of knockout muscles. To reveal quantitative
changes to the muscle proteome between control, obscurin-
knockout, Obsl1-knockout, or dKO mice, we isolated proteins
from TA and Sol muscles. We specifically focused on changes
between control and dKO muscles to eliminate compensatory
mechanisms between Obsl1 and obscurin that could potentially
obfuscate results. Of the 1503 and 1597 detected proteins in TA
and Sol of all genotypes, we identified 260 and 181 proteins that
were significantly deregulated between dKO and control muscles,
respectively (Fig. 4a, b, Supplementary Figs. 8, 9, Supplementary
Data File 1). Gene ontology (GO) term and pathway analysis of
significantly changed proteins from all investigated muscles, or
Sol and TA alone revealed enrichment of oxidative phosphor-
ylation, TCA (tricarboxylic acid) cycle, and electron transport
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Fig. 2 Loss of obscurin and/or Obsl1 (obscurin-like 1) does not influence muscle weights, and has little impact on cross-sectional area and muscle
regeneration. a Muscle weight to tibia-length ratios of tibialis anterior (TA), soleus (Sol), gastrocnemius (GC), and extensor digitorum longus (EDL)
muscles in control (CTL), obscurin knockout (Obsc), Obsl1 skeletal muscle-knockout (Obsl1), and double-knockout mice (dKO). Sample sizes (n) are
indicated in the figure; ***p < 0.001 vs. CTL. b–e Wheat germ agglutinin (WGA)- (magenta) and 4′,6-diamidino-2-phenylindole (DAPI)- (green) stained
immunofluorescence of frozen TA cross-sections (b) used to determine fibers with centralized nuclei (c) and cross-sectional fiber areas for each
group (d, e). Scale bar= 200 µm. Muscle from three mice per group were analyzed, counted fibers (n) and p values are indicated in figure (c–e). *p < 0.05,
***p < 0.001 vs. CTL. Box and whisker plots in c and d depict 5–95 percentile, averages (as cross) and outliers
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-019-0405-7
4 COMMUNICATIONS BIOLOGY |           (2019) 2:178 | https://doi.org/10.1038/s42003-019-0405-7 | www.nature.com/commsbio
chain, as well as muscle contraction processes (Supplementary
Fig. 3a–c, Supplementary Data Files 2–4). Among the sig-
nificantly upregulated proteins in TA muscles of dKO mice are
FlnC and Dysf, corroborating results obtained in our immunoblot
analyses (Figs. 3d, 4c, Supplementary Fig. 2d). Comparison of
significantly changed proteins between TA and Sol revealed 15
proteins as commonly upregulated and 33 proteins as commonly
downregulated in both analyzed muscle types, including
calsequestrin-2 (Casq2), Hspb1 (also known as Hsp27), myotilin,
or calmodulin-1 (Fig. 4b, Supplementary Data File 1). Intrigu-
ingly, we also noticed several proteins that were differentially
regulated between Sol and TA, including αB-crystallin (Fig. 4c, d,
Supplementary Figs. 2f, 7b). Indeed, when studied in immunoblot
assays of protein lysates from TA and Sol muscles from all
groups, only TA muscle of dKO mice showed significantly
increased αB-crystallin levels, while αB-crystallin levels in Sol
muscles remained largely unchanged (Fig. 4e, Supplementary
Figs. 2f, 7b). These muscle type-specific differences may be
reflective of the differential expression levels of obscurin splice
isoforms observed in these muscles, and/or on the muscle type
(fast vs. slow twitch)12,36.
Removal of obscurin/Obsl1 alters SR protein levels. Our
enrichment analysis revealed several proteins involved in muscle
contraction, calcium handling, and signaling as significantly
changed in dKO muscles. Among them, the SR proteins sar-
coendoplasmic reticulum Ca2+ ATPase (Serca), sarcalumenin,
triadin, JP-45 and junctin were found to be deregulated in dKO
muscles (Fig. 5a). We corroborated suspected changes to the SR
and its associated proteins by immunoblot analyses, and found a
significant reduction of Serca levels, while ryanodine receptors
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Fig. 3 Loss of obscurin and Obsl1 (obscurin-like 1) impacts dystrophin–sarcoglycan (DSG) complex and its associated proteins, membrane integrity and
membrane repair mechanisms. a Expression levels of DSG complex proteins dystrophin, utrophin, β-dystroglycan, and α-dystrobrevin, as well as α-tubulin
and β1D-integrin in whole protein lysates of tibialis anterior (TA) muscles of control (CTL), obscurin-knockout (Obsc), Obsl1 skeletal muscle-knockout
(Obsl1), and double-knockout (dKO) mice. Ponceau-stained actin band is shown as a loading control. b Subsarcolemmal dystrophin localization in
longitudinal sections of CTL, Obsc, Obsl1, and dKO TA muscles. Sarcomeric α-actinin 2 was used as counterstain. Scale bar= 10 µm. c Mouse
immunoglobulin (magenta) and 4′,6-diamidino-2-phenylindole (DAPI) stain (green) of frozen cross-sections of CTL, Obsc, Obsl1, and dKO TA muscles.
Arrowheads indicate immunoglobulin G (IgG)-positive muscle fibers. Scale bar= 200 µm. d, e Protein expression levels of dysferlin and Filamin-C (d), as
well as DSG-associated proteins α-syntrophin, Trpc1, caveolin-1, neuronal nitric oxidase (nNOS), and L-type calcium channel DHPR α-2 subunit (e) in whole
lysates of CTL, Obsc, Obsl1, and dKO TA muscles. Ponceau-stained actin is shown as a loading control
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(RyRs) were upregulated (Fig. 5b, Supplementary Figs. 2g, 7c).
We also investigated levels of sAnk1.5, which was shown to be a
binding partner for the obscurin-A C terminus. As shown before,
loss of obscurin resulted in a decrease in sAnk1.5 levels due to
increased turnover of the protein. Loss of Obsl1 did not affect
sAnk1.5 levels, while muscles from dKO mice displayed sAnk1.5
levels comparable with those found in obscurin knockouts
(Fig. 5b, d). Our proteome data also indicated changes to
calcium-binding proteins located within the lumen of the SR. We
tested protein levels of Casq1, Casq2, and sarcalumenin by
immunoblot analyses of whole muscle lysates. Sarcalumenin
levels decreased significantly between control and dKO muscles,
while Casq2 protein levels increased, and Casq1 remained
unchanged (Fig. 5c, e, Supplementary Figs. 2g, 7c).
These data indicate changes to cellular calcium handling in
dKO muscles, which may be reflected in defective excitation
contraction coupling and muscle contraction. To investigate if
these molecular changes alter muscle physiology, we studied EDL
twitch parameters in all groups (Table 2). EDL muscles of
obscurin-knockout and dKO mice displayed increased time-to-
peak (TtP) values compared to muscles from control and Obsl1
knockouts (Fig. 5f). However, half-relaxation times remained
unchanged (Fig. 5g).
Metabolic changes in obscurin/Obsl1-knockout mice. A sur-
prising result of the enrichment analysis was the large number of
significantly changed proteins belonging to metabolic pathways
and the mitochondrial electron transport chain (Fig. 6a). Speci-
fically, we found increased levels of Gbe1 (1,4-α-glucan branching
enzyme 1) and Stbd1 (starch binding domain 1) in dKO Sol and
TA muscles. Both proteins are involved in glycogen metabolism,
increasing solubility of glycogen by branching, and its breakdown
through glycophagy, respectively. Conversely, the rate determin-
ing enzyme responsible for glycogen breakdown, muscle glycogen
phosphorylase, was significantly decreased in dKO mice. We also
found significantly decreased levels of monoamine oxidase A and
B (Maoa, Maob) in TA muscles of dKO mice, while Sol muscle of
dKO mice had increased levels of catalase, perhaps indicative of
increased oxidative stress. Another finding was that Gapdh pro-
tein levels were decreased in dKO mice, a result that we also
consistently observed in Obsl1-knockout cells and tissues
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(Supplementary Figs. 1b, 4a, 4b), necessitating the use of total
protein, actin or myosin, for normalization. Most intriguingly,
however, almost all identified mitochondrial electron transport
chain proteins were downregulated in dKO mouse Sol and TA
muscles (Fig. 6b, Supplementary Fig. 4c). Analysis of whole TA
and/or Sol muscle extracts using the oxphos antibody cocktail or
a Uqcrb antibody substantiated slightly or significantly decreased
levels of mitochondrial complex I, II, III, IV, and V proteins in
dKO mice (Fig. 6c, Supplementary Fig. 4d–f). Analysis of Prdx3
protein levels, a mitochondrially targeted peroxiredoxin family
member37 that was also detected in our proteome analysis as
significantly altered, indicating that the effect of Obsl1/obscurin
loss on the mitochondria may go well beyond electron transport
chain proteins (Fig. 6c, Supplementary Fig. 4e, f). Further analysis
of the proteome data revealed that downregulation of electron
transport chain proteins is more associated with loss of obscurin
than Obsl1 (Supplementary Fig. 4c). However, only the loss of
both proteins, obscurin and Obsl1, resulted in the substantial
reduction in mitochondrial proteins. It remains to be demon-
strated if these changes are mirrored on the physiological level,
and if dKO muscles display altered reactive oxygen species (ROS)
levels caused by mitochondrial insufficiency. Our proteome data
showing changes to other peroxiredoxins, Sod2, and other pro-
teins involved in ROS scavenging and signaling (Supplementary
Fig. 5e; Supplementary Data File 1) are highly suggestive of this
possibility.
Discussion
Our study set out to investigate biological roles for Obsl1, with a
specific focus on redundant functions between obscurin and Obsl1
for the development of skeletal muscles. For this, we generated
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Table 2 Twitch parameter analysis on 4-month-old mice
Parameters CTL Obsc Obsl1 dKO
Number of analyzed muscles (females/males) 10 (6/4) 7 (3/4) 9 (4/5) 10 (4/6)
TtP (ms) 21.45 ± 1.02 26.14 ± 0.91** 21.56 ± 0.92 25.3 ± 0.74**
HRT (ms) 43.3 ± 2.81 42.86 ± 3.20 48.00 ± 5.68 46.5 ± 1.99
Full-width at half-maximum (ms) 57 ± 3.4 60 ± 3.9 63 ± 6.3 64 ± 2.6
Stress during tetanus (kPa) 71 ± 3.8 99 ± 5** 79 ± 6.2 70 ± 5.8
PCSA (mm2) 0.51 ± 0.027 0.61 ± 0.023 0.6 ± 0.034 0.55 ± 0.03
EDL muscle mass (mg) 3.4 ± 0.19 4 ± 0.22 4.3 ± 0.28** 3.9 ± 0.18
Fiber length (mm) 6.2 ± 0.11 6.1 ± 0.16 6.7 ± 0.13* 6.5 ± 0.2
Values are presented as averages and standard error of mean. Samples sizes are shown in the table; p values are **p < 0.01 or *p < 0.05 vs. CTL
TtP time to peak, HRT half-relaxation time, PCSA physiological cross-sectional area, CTL control, Obsl1 obscurin-like 1, dKO double knockout, EDL extensor digitorum longus
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conditional Obsl1-knockout mice using a strategy that prevents
the expression of all Obsl1 isoforms. Surprisingly, our global Obsl1
knockouts display an embryonic lethality phenotype (Table 1).
Obsl1 has been shown to be responsible for ~20% of cases of
3M-growth syndrome, while mutations in cullin-7 and Ccdc8
account for the remainder of the patients27,31. Most of the Obsl1
patients suffer from mutations that result in a truncated protein
due to frameshift mutations31,38. These findings led to the spec-
ulation that the Obsl1 mRNA in patients may be prematurely
degraded by nonsense-mediated decay, resulting in complete
absence of the protein31. However, similar to cullin-7 knock-
outs39, our global Obsl1 knockouts do not recapitulate the 3M-
growth syndrome exhibited by patients.
Closer analysis showed that all Obsl1 mutations are located
well 3′ of the sequence encoding for Ig domain 1 of Obsl131. This
leaves the potential open for low-level expression of C terminally
truncated Obsl1 protein variants and alternative splice isoforms
that circumvent some of the deleterious mutations in Obsl1,
which is not possible in our mouse model. However, immunoblot
analysis of Obsl1 using validated antibodies has not been exten-
sively done on patient samples.
It is difficult to compare data from the 3M-growth syndrome
transcriptome and the Obsl1 interactome35,40 with changes
observed in our proteome analyses, as there are functional
redundancies between Obsl1 and obscurin, which may not be
present in skin fibroblasts and other non-muscle tissues (Sup-
plementary Fig. 6a). Moreover, the complete dataset for the
transcriptome analysis of fibroblasts from 3M-growth syndrome
patients is not readily available40. However, there are several
striking similarities between our proteome and the transcriptome
and interactome datasets (Supplementary Fig. 5a, b; Supple-
mentary Data File 5). Specifically, both studies found significant
deregulation of genes/proteins involved in cellular transcription
(e.g., Hnrnpf, Eef1a1, Ybx transcription factors), translation
(small and large ribosomal subunits), and in genes involved in
metabolic pathways downstream of IGF1 (insulin-like growth
factor 1) and mTOR (mammalian target of rapamycin) signaling
(Supplementary Fig. 5c). Several proteins that form part of
membrane and vesicle trafficking complexes show up in both
large datasets, including coatomer protein complex subunit
alpha (Copa) or clathrin (Cltc) (Supplementary Fig. 5a, d). In
addition, other proteins involved in vesicle and protein trafficking
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were found significantly altered, such as caveolin-3, muscle-
related coiled-coil protein (MuRC/cavin-4)41, transferrin receptor
(Tfrc)42, intersectin-1 (Itsn1)43, Rab8b44, non-clathrin-related
endocytosis (pacsin345, EHD346), COP1- or COP2-related pro-
tein shuttling pathways (Sec31a47,48, archain-1 (Arcn1)49), and
several tubulin isoforms, which were also deregulated in our
proteome analysis (Supplementary Data 1). Deficiencies in several
of these pathways have been implicated in growth retardation and
developmental delays, including COP-related protein shuttling
pathways49–51 or clathrin-dependent trafficking52. Another
striking overlap between the datasets are proteins that are
involved in metabolism, mitochondrial function (e.g., electron
transport chain complex proteins), and generation/scavenging of
ROS). Specifically, we found deregulation of Gapdh and Prdx3,
both identified as putative interaction partners for Obsl135
(Supplementary Figs. 5a, 6c). Maoa was also found down-
regulated in both the transcriptome and our proteome datasets.
Patients with Maoa/Maob deficiency display loss of muscle tone
and short statue53,54, while global Maoa/Maob dKO mice show
developmental delays, behavior, and locomotion problems55.
Closer examination of changes to muscles and exercise capacity in
monoamine oxidase-deficient mice remains to be done.
It is thought that 3M-growth syndrome is caused by a defi-
ciency in protein turnover due to the finding that a majority of
patients with 3M-growth disorder display mutations in cullin-7,
Obsl1, and Ccdc8. Indeed, Obsl1 was identified as a binding
partner for the E3-ubiquitin ligase cullin-725,26,56. However, our
proteome data did not reveal significant changes to any of the
other proteins associated with the disease, that is, cullin-7, Ccdc8,
Fbw8, Igfbp2, or Igfbp5. These findings raise the possibility that
functional deficiencies associated with the disorder may be tissue
specific and spare skeletal muscles. Closer examination of
expression patterns for 3M-growth syndrome associated proteins
could reveal tissues types where this complex performs its major
functions. Indeed, looking at expression profiles in Protein Atlas
(https://www.proteinatlas.org/) reveals variable expression for
Fbw8 (and many of the other F-box-containing substrate adaptor
proteins for cullin-7), as well as Igfbp2 and Igfbp5 across tissues.
The usage of cre lines that delete Obsl1 in tissues other than
skeletal muscles and at earlier time-points will shed further light
into non-muscle functions for Obsl1 and the development of 3M-
growth syndrome.
Another surprise was the lack of baseline phenotype for skeletal
muscle-specific Obsl1 knockouts, and the comparatively mild
physiological phenotype observed for the dKO mice. Indeed,
looking at the substantial molecular changes to the DSG complex,
alterations to sarcolemmal integrity and to SR-associated proteins
that the dKO mice display, it was unexpected to observe no changes
to the number of centralized nuclei in muscle cross-sections as a
sign for active muscle regeneration, and largely unchanged phy-
siological twitch parameters. However, when investigating specific
alterations to skeletal muscles upon loss of Obsl1 and obscurin
redundant functions for both proteins start to emerge.
Despite extensive interactions of obscurin and Obsl1 (or its
invertebrate homolog unc-89) with sarcomeric proteins8,11,33,57,
loss of either or both obscurin family proteins had negligible
effects on myofibrillogenesis and sarcomere structure. Indeed,
apart from a slight reduction in the levels of myomesin-2 (Sup-
plementary Fig. 1e), we were unable to detect any overt changes
for myomesin-1, tropomyosin, α-actinin 2, titin-M8, and myosin
localization or expression. These data indicate that obscurin and
Obsl1 in vertebrate muscles are sarcomere-associated proteins
that are not required for sarcomere assembly. Indeed, our
experiments investigating muscle twitch characteristics only
found increase in TtP values for loss of obscurin, indicative of
problems with the SR and calcium-induced calcium release.
However, no changes were found in other parameters measured
in these experiments, with the exception of stress during tetanus
values for obscurin knockouts. Obsl1 has been shown to target to
several subcellular localizations in heart and skeletal muscles,
including M-band, Z-disc, and intercalated discs8,11. While not all
antibodies in these studies have been verified against the knock-
out, our experiments using two verified Obsl1 antibodies that
target different Obsl1 epitopes corroborate several of these find-
ings. Known and novel interactions may explain the differential
Obsl1 localization to sarcomeric M-bands and Z-discs (Fig. 1c,
Supplementary Figs. 1a, 1d, 1e, 6b). It remains to be demon-
strated how splice variants of Obsl1, and binding affinities to
interactors modifies the subcellular localization.
Obscurin knockouts display altered ankyrin-B and dystrophin
localization at costameres, and increased membrane fragility
combined with reduced muscle exercise tolerance13,14.
Morpholino-mediated knockdown of obscurin-A in zebrafish also
resulted in abnormal dystrophin and α-dystroglycan localization,
suggesting evolutionary conserved functions of obscurin for DSG
complex organization and sarcolemmal integrity58. Following
these studies, we investigated expression and localization of DSG
components and found changes at baseline predominantly in
dKO mice. While dKO muscles did not display changes to dys-
trophin levels, its subsarcolemmal localization appeared patchy
and its distribution disturbed. Immunofluorescence imaging of
subsarcolemmal dystrophin indicated that obscurin and Obsl1
may partially modulate the membrane targeting of dystrophin,
and help it to spread evenly over the sarcolemmal membrane
(Fig. 3b, Supplementary Fig. 2b).
Muscles of dKO mice also displayed a surprising slight
decrease in utrophin (p= 0.06), and several other investigated
DSG components, including α-dystrobrevin. Moreover, DSG-
linked signaling via ion channels (Trpc1) may also be altered in
dKO mice only, based on reduced expression levels of this
channel. These data suggest that both Obsl1 and obscurin have
redundant functions for DSG complex assembly and stability.
Loss of both proteins resulted in impaired sarcolemmal integrity
in a substantial proportion of muscles in mice at baseline (not
exercised), as demonstrated by positive immunoglobulin labeling
of muscle fibers in dKO mice (Fig. 3c, Supplementary Fig. 2c).
Muscles of dKO mice also show upregulation of proteins
involved in muscle repair processes, including Dysf and FlnC59–61.
Future experiments that further characterize membrane damage
and studies that investigate repair mechanisms through FlnC and
Dysf should clarify the extent of the sarcolemmal integrity
impairment in dKO mice.
While some of the functions that obscurin exerts on the DSG
complex are due to interactions with ankyrin isoforms, spectrin
and FlnC13,20,21,62,63, we and others identified that Obsl1 may
interact with other proteins linked to the DSG complex and its
associated components35, including FlnC, tubulin, dystonin,
plectin, ahnak, and utrophin (Supplementary Figs. 1a, 5a, 6c).
Obsl1/obscurin function has also been implicated for microtubule
integrity, by promoting microtubule assembly and/or
stability13,14,64. Microtubule action is important for SR organi-
zation65, sarcolemmal integrity and repair66,67, cell division, cel-
lular shape, and the transport of vesicles over longer distances, in
addition requiring actions of kinesin and dynein as molecular
motors68. When looking at the proteome data, we noticed
increases in α- and β-tubulins, which can be verified in immu-
noblot analyses of dKO TA muscles (Fig. 3a, Supplementary
Fig. 2a). Alterations in the microtubule network have also been
linked to the development of muscular dystrophy in mdx mice69.
Dystrophin was shown to interact with microtubules70,71, and its
loss increased the amounts of both α- and β-tubulins69, a finding
that is similar to what is seen in our dKO mice.
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One of the key findings in skeletal muscles of obscurin
knockouts was the importance of the protein for SR architecture
through its link with the small muscle-specific ankyrin-1 isoform
sAnk1.5 that is embedded in the SR membrane20,21. While loss of
Obsl1 has little or no impact on protein levels of SR-associated
proteins, muscles of dKO mice displayed profound alterations to
levels of lumenal SR calcium-binding proteins sarcalumenin and
Casq2, as well as Serca. Our proteome and expression data also
indicated increases to junctional SR proteins like triadin, junctin,
or RyRs in dKO muscles, something not previously observed for
obscurin knockouts12. One might speculate based on the pre-
dominant subcellular localizations of obscurin at the M-band and
Obsl1 at the M-band and Z-disc that both the longitudinal and
junctional SR are affected in dKO muscles. Data on DSG-
associated ion channels (Trpc1), the junctional (RyR) or long-
itudinal SR membranes (Serca), suggests that loss of obscurin/
Obsl1 alters calcium handling in dKO muscles. These data in
combination with published findings on Speg17 and the inverte-
brate homolog unc-8972 substantiates the finding that the reg-
ulation of SR architecture and function is a major biological role
for all obscurin protein family members.
Many questions remain unanswered as to the exact molecular
origins for the observed effects in dKO muscles. Our proteome
analyses may provide clues for some of the molecular mechan-
isms at play that could result in alterations to the cellular meta-
bolism, changes to membrane stability and repair mechanisms,
and the impact on calcium handling and Serca function/regula-
tion. However, none of the well-characterized muscle-specific
obscurin and Obsl1 interaction partners may account for all of
the observed phenotypical changes2,11,20,21,25,26,57,73. Indeed, it
remains to be demonstrated for the majority of the more than 600
identified binding partners of obscurin and Obsl135, whether they
play a role in muscles, and how loss of both obscurin protein
family members affect their expression, localization, and cellular
functions.
Methods
Gene targeting and generation of Obsl1-knockout mice, analysis of animal
physiology. The targeting construct was generated by subcloning isogenic 129svj
genomic DNA fragments of the murine Obsl1 gene into a targeting vector, and
placing coding exons 1 to 4 between loxP sites (Supplementary Fig. 1a). The
construct was linearized, and electroporated into R1 embryonic stem cells. G418-
resistant clones were screened for correct homologous recombination by Southern
blot analysis described elsewhere12. Germline transmission was tested by appear-
ance of the agouti fur color phenotype of 129-derived ES-cells, after which animals
were backcrossed into the black swiss background. Genotying was done by PCR
using oligonucleotides shown in Supplementary Table 1. Removal of neomycin
cassette was done by crossing floxed Obsl1 mice with mice carrying Flpase
recombinase74,75. Generation of global Obsl1 knockouts was done by crossing
floxed Obsl1 mice with mice carrying Cre recombinase under control of the pro-
tamine promoter30. Finally, generation of skeletal muscle-specific Obsl1 knockouts
was achieved by crossing floxed Obsl1 mice with mice carrying Cre recombinase
under control of the myogenin promoter32. Successful recombination of Obsl1 gene
and generation of skeletal muscle knockouts was validated by immunoblot analyses
(Fig. 1a). Generation of obscurin/Obsl1 myogenin-cre dKOs was done by cross-
breeding into the obscurin knockout background12. If not explicitly stated, all
investigations were done with tissues from animals of both sexes. Experiments
using the fifth toe of the EDL muscle from 4-month-old mice was done as
described previously12. All procedures involving genetically modified animals have
been approved by the UC San Diego institutional oversight committee.
Cell culture. Culture of cos-1 cells was done as previously described76,77. To test
Obsl1 antibodies and to determine if effects seen in dKO and Obsl1-knockout
muscles are also seen in non-muscle Obsl1-knockout cells, we isolated cells from
lungs of heterozygous global Obsl1 knockouts (+/−) and from mice that have a
knockout and a floxed allele for Obsl1 (flox/−), using a collagenase/dispase enzyme
mix (Roche). Isolated cells were cultured and propagated in growth medium (10%
fetal calf serum, 1% penicillin/streptomycin, Dulbecco’s modified Eagle’s medium
[Corning]). To generate Obsl1 knockouts, cells were transduced with a lentivirus
carrying a cre-blasticidin-RFP expression cassette under control of a CMV pro-
moter (#LVP013; Gentarget Inc.), allowing for recombination of the Obsl1-floxed
allele and selection of transduced cells by 5 µg/ml blasticidin (Thermo Fisher).
After transduction, cells were kept in growth medium supplemented with blas-
ticidin until harvest for analysis of proteins.
Protein analysis, immunofluorescence, histology, and antibodies. For analysis
of protein levels, muscles or cells were lysed directly into sample buffer (3.7 M urea,
134.6 mM Tris-HCl, pH 6.8, 5.4% sodium dodecyl sulfate (SDS), 2.3% NP-40,
4.45% β-mercaptoethanol, 4% glycerol, and 6 mg/100 ml bromophenol blue).
Loading was normalized by densitometry of Coomassie-stained gels using either
actin or myosin bands. Once normalized, muscle lysates were loaded onto SDS-
polyacrylamide gel electrophoresis (PAGE) gels (8, 12, or 15% acrylamide con-
centration) or SDS-Agarose gels12. Proteins were transferred onto nitrocellulose
membranes, and detection of proteins was done using antibodies as described
elsewhere77. If not stated otherwise, biological replicates were used for immunoblot
analyses. Sample sizes for quantification of protein levels are given in the figure or
figure legend. Uncropped blot images for all western blot data are presented in
Supplementary Data File 6.
For immunofluorescence, muscles were isolated, snap frozen while submerged
in isobutane, and embedded into cryogenic molds using optimal cutting temperate
(OCT) medium. Longitudinal or cross-sections of muscles were done by
cryosectioning using a cryostat (Leica). Sections were collected on surface-treated
microscopy glass slides (Colorfrost Plus, Fisher), dried, and stored at −80 °C until
further use. Immunofluorescent staining of sections was done by fixing sections in
ice-cold acetone (5 min at −20 °C), rehydration of tissue using 1× phosphate-
buffered saline (PBS) (5 min), permeabilization (1× PBS, 0.2% Triton X-100; 5
min), and blocking with 1% bovine serum albumin (BSA) fraction V and 5%
normal donkey serum diluted in Gold Buffer (155 mM NaCl, 2 mM EGTA, 2 mM
MgCl2, 20 mM Tris-HCl, pH 7.5) for 30 min. After blocking of non-specific
binding sites, tissue sections were incubated with primary antibody diluted in Gold
Buffer overnight at 4 °C. Following three washes with PBS (5 min each), sections
were incubated with fluorescently labeled secondary antibodies combined with
either 4′,6-diamidino-2-phenylindole (DAPI) and/or fluorescently labeled wheat
germ agglutinin (WGA) (Sigma) diluted into Gold Buffer for 2 h at room
temperature. After washing with 1× PBS (5 min each), sections were embedded
using fluorescent mounting medium (DAKO), and covered with coverslips.
Immunofluorescently labeled tissues were imaged using a Fluoview 1000 confocal
microscope (Olympus), in sequential scanning mode using ×10 air or ×40 oil
objectives and zoom rates between 1× and 3×. For analysis of cross-sectional areas,
images were analyzed using the area-measuring tool in ImageJ.
Primary antibodies used in this study are listed in Supplementary Table 2. If not
noted otherwise, all secondary antibodies were either from DAKO or Jackson
ImmunoResearch. Fluorescently labeled WGA was obtained from Invitrogen/
Thermo Fisher. DAPI was purchased from Sigma-Aldrich.
Mass spectrometry and proteome analysis. Proteins were isolated form whole
muscle and lysed into ice-cold isolation buffer (300 mM KCl, 30 mM PIPES pH 6.6,
0.5% NP-40, 1× protease inhibitor (Roche), 1× Phos-stop (Roche)). Insoluble
proteins were removed by centrifugation (14,000 rpm, 10 min at 4 °C), and the
supernatant was diluted 1:4 with ice-cold dilution buffer (1× Phos-stop (Roche),
0.5% NP-40, 1 mM dithiothreitol (DTT)). Precipitation of acto-myosin compo-
nents was done by centrifugation (14,000 rpm, 15 min at 4 °C), and the remaining
supernatant snap frozen for further analysis by mass spectrometry and immuno-
blot analyses.
Analysis and identification of peptides via mass spectrometry was done as
described previously78. Briefly, immediately prior to mass spectrometry, protein
solutions were diluted in TNE buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1
mM EDTA). RapiGest SF reagent (Waters Corp.) was added to the mix to a final
concentration of 0.1% and samples were boiled for 5 min. TCEP (Tris (2-
carboxyethyl) phosphine) was added to a final concentration of 1 mM, and the
samples were incubated at 37 °C for 30 min. Subsequently, the samples were
carboxymethylated with 0.5 mg/ml of iodoacetamide for 30 min at 37 °C, followed
by neutralization with 2 mM TCEP (final concentration). Protein samples prepared
as above were digested with trypsin (trypsin:protein ratio of 1:50) overnight at 37 °
C. RapiGest was degraded and removed by treating the samples with 250 mM HCl
at 37 °C for 1 h, followed by centrifugation at 14,000 rpm for 30 min at 4 °C. The
soluble fraction was then added to a new tube and the peptides were extracted and
desalted using C18 desalting tips (Thermo Scientific).
The trypsinized samples (eight samples) were labeled with isobaric tags
(iTRAQ8, ABSCIEX)79, where each sample was labeled with a specific tag to its
peptides as described in the manufacturer’s instructions. Each set of experiments
were then pooled and fractionated using high pH reverse phase chromatography
(HPRP-Xterra C18 reverse phase, 4.6 mm × 10mm, 5 µm particle [Waters]). The
chromatography conditions were as follows: the column was heated to 37 °C and a
linear gradient from 5 to 35% B (Buffer A—20 mM ammonium formate pH 10
aqueous, Buffer B—20 mM ammonium formate pH 10 in 80% acetonitrile (ACN)-
water), followed by 5 min at 100% B was applied for 80 min at 0.5 ml/min flow rate.
A total of 42 fractions of 0.5 ml volume were collected. For liquid chromatography
with tandem mass spectrometry (LC-MS/MS) analysis, some fractions were pooled
to create a final 16 pooled samples. Each of the pooled fractions were analyzed by
high pressure liquid chromatography coupled with LC-MS/MS using nano-spray
ionization.
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Nano-spray ionization experiments were performed with a TripleTof 5600
hybrid mass spectrometer (ABSCIEX) interfaced with nano-scale reversed-phase
UPLC (Waters Corporation, nanoACQUITY) using a 20 cm × 75 µm ID glass
capillary packed with 2.5 µm C18 (130) CSHTM beads (Waters Corporation). A
linear gradient (5–80%) of ACN was used to elute the peptides from the C18
column into the mass spectrometer at a flow rate of 250 μl/min for 1 h. The ACN
gradient was created with the following buffers: Buffer A (98% H2O, 2% ACN, 0.1%
formic acid, and 0.005% trifluoroacetic acid (TFA)) and Buffer B (100% ACN, 0.1%
formic acid, and 0.005% TFA). MS/MS data were acquired in a data-dependent
manner in which the MS1 data was acquired for 250 ms at m/z of 400 to 1250 Da
and the MS/MS data was acquired from m/z of 50 to 2000 Da. Independent data
acquisition parameters were as follows: MS1-TOF (mass spectrometry imaging-
time of flight) acquisition time of 250 ms, followed by 50 MS2 events of 48 ms
acquisition time for each event. The threshold to trigger MS2 event was set to 150
counts when the ion had the charge state +2, +3, and +4. The ion exclusion time
was set to 4 s. The collision energy was set to iTRAQ experiment setting. Finally,
the collected data were analyzed using Protein Pilot 5.0 (ABSCIEX) for peptide
identifications and Peaks80. Bioinformatic enrichment and pathway analysis was
done using Metascape (http://metascape.org/)81, Morpheus (https://software.
broadinstitute.org/morpheus/), the BioGRID (https://thebiogrid.org/)82, and
Venny (http://bioinfogp.cnb.csic.es/tools/venny).
Eukaryotic expression constructs, yeast two-hybrid screening, and co-
immunoprecipitation. Constructs for green fluorescent protein (GFP)-tagged
Obsl1 fragments and yeast two-hybrid screening were generated as described
elsewhere24. In short, coding sequences for human Obsl1 fragments (NCBI access
no: NM_178884) were subcloned to enhanced GFP (EGFP) (Clontech) or pLex
vectors to produce in-frame fusion between GFP or the DNA-binding domain and
the insert. All expression constructs were sequenced to determine correct inte-
gration into the vector. The yeast two-hybrid screening was done as described
previously77. Briefly, L40 yeasts were transformed with bait constructs (pLex-Obsl1
domain truncations) and empty prey vector (pAct2) to perform auto-activation
test. pLex-Obsl1 constructs that were negative for auto-activation were selected for
further yeast two-hybrid screening. L40 yeasts were transformed with selected
pLex-Obsl1 constructs, and positive transformants were used to perform a library
transformation. Yeasts were plated on selective dropout plates, and colonies were
allowed to form for 5 days. Yeast clones positive for β-galactosidase activity in an
X-gal overlay assay were further amplified, and library plasmid DNA was extracted
and analyzed by sequencing.
Transfection of Cos-1 cells was done as described previously77. Transfected cells
were lysed into ice-cold immunoprecipitation (IP) buffer (100 mM NaCl, 10 mM
Tris-HCl, pH 8, 1× Complete Protease Inhibitor Cocktail [Roche], 1 mM DTT, and
0.5% NP-40) 2 days after transfection. Lysates were briefly sonicated, centrifugated
for 10 min at 14,000 rpm (at 4 °C) to remove insoluble proteins, and supernatants
were used to perform immunoprecipitation. Briefly, 5 µg GFP antibody (Roche)
were added to lysates, and incubated overnight at 4 °C to allow for formation of
immunocomplexes. Subsequently, magnetic protein-G-coated beads (Dynabeads,
Life Technologies) were added and incubated for 3 h at 4 °C on a shaker. Bound
protein immunocomplexes were separated from unbound proteins by magnetic
separation, and the beads were washed three times with ice-cold wash buffer (1×
PBS, 0.2% NP-40). Analysis of input and bound protein immunocomplexes was
done by SDS-PAGE, followed by immunoblot analysis.
Bioinformatics and statistical analysis. The following bioinformatics packages
and programs were used to perform analyses in this manuscript: analysis of pro-
teome data was done using Peaks Studio (http://www.bioinfor.com/peaks-studio/)80;
pathway enrichment analysis was done with the help of MetaScape (http://
metascape.org/)81; hierarchical clustering of proteome data was done using Mor-
pheus (https://software.broadinstitute.org/morpheus/); image analysis was done
using ImageJ with the LOCI BioFormats and Image5D plugins (by the Open
Microscopy Environment consortium and Joachim Walter, respectively); sequence
alignments and domain structure analysis were done using NIH/NCBI BLAST
(https://blast.ncbi.nlm.nih.gov/Blast.cgi), SDSC Biology Workbench (http://
workbench.sdsc.edu/), and SMART (http://smart.embl-heidelberg.de/)83. With the
exception for built-in statistics by the Peaks Studio software, statistical analysis of all
data was done by using analysis of variance comparison, followed by Dunnett’s
multiple comparisons test, or unpaired t test, performed using Excel (Microsoft) or
GraphPad Prism version 7 for Mac (GraphPad Software, http://www.graphpad.com).
Violin plots were generated using BoxPlotR (http://shiny.chemgrid.org/boxplotr/).
Results are presented as means ± standard error. P values of p < 0.05 were considered
statistically significant. Sample sizes are indicated in the figure or figure legend. If not
stated otherwise, both sexes were analyzed in the experimental procedures. We used
biological replicates to showcase biological variability and reproducibility of findings.
Whenever appropriate, different methods were used to verify a finding (e.g., inter-
action found in yeast two-hybrid screening was verified by co-immunoprecipitation).
No data were excluded in the generation of figures/tables, with the exception of two
lanes in Supplementary Fig. 7b (upper panel) that did not pass the quality control as
judged by Ponceau stain.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data described in the manuscript can be found in the figures, tables, and
supplemental files, are deposited in public repositories, or can be requested from the
authors. The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository84,85 with the dataset
identifier PXD013008 and https://doi.org/10.6019/PXD013008.
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